Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
Completed · Phase 3
Conditions studied: Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Veno-occlusive Disease
In brief
RATIONALE: Dalteparin may be effective in inhibiting the growth of blood vessels in tumors, decreasing the risk of metastatic cancer, preventing the formation of blood clots, and improving quality of life in treating patients with advanced cancer that has not responded to previous treatment. It is not yet known if standard therapy is more effective with or without dalteparin in treating advanced breast, lung, colorectal, and prostate cancer. PURPOSE: Randomized double blinded phase III trial to compare the effectiveness of standard therapy with or without dalteparin in treating patients who have advanced breast, lung, colorectal, or prostate cancer that has not responded to previous chemotherapy or hormone therapy.
Key facts
- Study ID
- NCT00003674
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 141
- Starts
- 1998-12-01
- Expected to finish
- 2004-04-01
- Last updated by the study team
- 2016-07-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- CCOP - Scottsdale Oncology Program — Scottsdale, Arizona, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- CCOP - Cedar Rapids Oncology Project — Cedar Rapids, Iowa, United States
- CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
- Siouxland Hematology-Oncology — Sioux City, Iowa, United States
- CCOP - Wichita — Wichita, Kansas, United States
- CCOP - Ochsner — New Orleans, Louisiana, United States
- CCOP - Ann Arbor Regional — Ann Arbor, Michigan, United States
- CCOP - Duluth — Duluth, Minnesota, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- CentraCare Clinic — Saint Cloud, Minnesota, United States
- CCOP - Missouri Valley Cancer Consortium — Omaha, Nebraska, United States
- Medcenter One Health System — Bismarck, North Dakota, United States
- CCOP - Merit Care Hospital — Fargo, North Dakota, United States
- Altru Health Systems — Grand Forks, North Dakota, United States
- CCOP - Toledo Community Hospital Oncology Program — Toledo, Ohio, United States
- CCOP - Geisinger Clinic and Medical Center — Danville, Pennsylvania, United States
- Rapid City Regional Hospital — Rapid City, South Dakota, United States
- CCOP - Sioux Community Cancer Consortium — Sioux Falls, South Dakota, United States
- Allan Blair Cancer Centre — Regina, Saskatchewan, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.